Alx oncology says cash balance sufficient to fund planned ops through 2023

Alx oncology reports second quarter 2020 financial results and provides operational and clinical highlights.q2 revenue $500,000 versus $1.3 million.alx oncology holdings - believes cash balance is sufficient to fund planned operations through 2023.
ALXO Ratings Summary
ALXO Quant Ranking